Mindray To Host Renowned Critical Care Experts in Booth at NTI 2023


Mindray exhibiting at NTI 2023

Mindray exhibiting at NTI 2023

Mindray will be back again at the NTI in Philadelphia, Pennsylvania, to showcase its innovative solutions for advancing Critical Care and provide learning opportunities for attendees. Mindray invites all NTI attendees to visit Booth 1637.

Mindray, a global developer of technologies and solutions for patient monitoring, ultrasound, and anesthesia, today announced that they will be back again at the National Teaching Institute & Critical Care Exposition (NTI)2023 in Philadelphia, Pennsylvania to showcase its innovative solutions for advancing Critical Care and provide learning opportunities for attendees. Mindray invites all NTI attendees to visit Booth 1637 for live educational sessions led by well-known critical care expert Barbara McLean, MN, RN, CCRN, CCNS-BC, NP-BC, FCCM, and renowned clinical educator and speaker Nicole Kupchik, MN, RN, CCNS, CCRN, PCCN-K.

Mindray recognizes that delivering high-quality patient care in Critical Care Departments has never been more essential and is excited to continue its partnership with McLean and Kupchik, who presented the last eight years at the Mindray-sponsored ExpoEd Sessions. The two speakers will be back this year to address a variety of critical care topics, including “Monitoring Patients Receiving Opioids: Preventing Harm” and “Critical Principles: Pressure, Flow and Compliance.” These Mindray-sponsored ExpoEd sessions are part of the NTI Critical Care Expo running May 23 – 24. For the NTI Virtual Conference June 12-14, Mindray will sponsor the virtual Sunrise Session “Vasopressors and Vascular Tone” presented by Barbara McLean, with a live Q&A session following. Both the in-person and virtual Mindray-sponsored education opportunities will offer CERP credits.

“Mindray is eager to host Barbara McLean and Nicole Kupchik in our booth at NTI this year,” said Beth Aquaviva, Sr. Marketing Product Manager – Monitoring Solutions, Mindray North America. Aquaviva continued, “At Mindray, we recognize the importance of cutting-edge advancements and best practices in the field, which is why it is such an honor to partner with industry leaders like McLean and Kupchik to help facilitate learning opportunities for progressive and critical care nurses and continue advancing better healthcare for all.”

Additionally, Mindray will have its latest patient monitoring and point of care ultrasound products on display to offer hands-on learning in the booth, including a live scanning demo of its TE X Ultrasound System. Mindray invites all NTI attendees to explore their industry-leading technologies and solutions that help support timely and accurate assessment, diagnosis, and treatment of the most critically ill patients.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of lifesaving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in Silicon Valley, with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Comagine Health Strengthens Its Board of Directors With New Members


Our new board members offer diverse perspectives, strategic leadership and many years of experience that will amplify our success and enable us to transform the health care system together. – Marc Bennett, Comagine Health’s president and chief executive officer.

Comagine Health, a leading national nonprofit health care consulting firm, named additional board members recently. Marc Bennett, Comagine Health’s president and chief executive officer, recognized that a broader range of diverse expertise is needed at the board level to achieve the organization’s mission and vision.

“Comagine Health remains committed to reimagining health care, together,” Bennett said. “We rely on our board of directors to help us carry out our mission and vision. Our new board members offer diverse perspectives, strategic leadership and many years of experience that will amplify our success and enable us to transform the health care system together.”

The new board members are:

Steve Hansen, MPA — Mr. Hansen is the president and chief executive officer of Presbyterian Medical Services (PMS), a New Mexico-based nonprofit corporation whose mission is to design and deliver quality accessible integrated health, education and human services in response to identified community needs of the multicultural people of the Southwest. Through his leadership over the past 15 years, PMS has grown to a current budget of $140 million, employs 1,400, operates 110 individual sites and is Joint Commission-accredited.

Jim Wigfall, MBA — Mr. Wigfall is the chief executive officer of Sound Generations, a nonprofit organization with more than 200 employees and 1,400 volunteers providing food security, transportation, health and wellness, and assistance services to older adults and adults with disabilities throughout King County, Washington. He has served in this position since April 2018. Before joining Sound Generations, he spent more than 30 years with the Boeing Company. He retired at the end of 2017 as the vice president of the Shared Services Group (SSG) business partner, Boeing Commercial Airplanes.

Craig Wright, MD — Dr. Wright is an independent consultant and executive coach who works with health care organizations and leaders from across the country. He also currently serves as the chief medical officer for Waterfall Community Health Center. Dr. Wright has worked as a physician executive for more than 30 years and has run large medical groups in the Seattle and Portland markets, serving as the chief executive officer of Swedish Physicians in Seattle and senior physician leader in the Providence Oregon region as well as the Providence Health System corporate office in Renton, Washington.

Comagine Health’s corporate board is led by incoming chair Dorothy Teeter, MHA. Ms. Teeter served as a board member for 3 years before stepping into her role as board chair. She has over 30 years of public and private health system leadership with deep experience in population health services delivery and innovation in building value through clinical and community linkages. Ms. Teeter was the director of the Washington State Health Care Authority (HCA) and also held senior roles at the Center for Medicare and Medicaid Innovation (CMMI), Group Health Cooperative and Seattle Children’s Hospital.

New Comagine Health corporate board officers include:

  •     Andrew Croshaw, MBA — Vice Chair
  •     Katryna McCoy, Ph.D., FNP-C — Secretary
  •     Chris Bosse — Treasurer

###

About Comagine Health

Comagine Health works collaboratively with patients, providers, payers and other stakeholders to reimagine, redesign and implement sustainable improvements in the health care system. As a trusted, neutral party, we work in our communities to address key, complex health and health care delivery problems. In all our engagements and initiatives, we draw upon our expertise in quality improvement, care management, health information technology, analytics and research. We invite our partners and communities to work with us to improve health and redesign the health care delivery system. For more information, please visit comagine.org.

Share article on social media or email:

PDA Announces Three Speakers from the U.S. FDA for ATMP Conference


The 2023 PDA ATMP Conference

The conference’s theme, “Navigating through CMC Challenges,” was developed to ensure attendees expand their knowledge and understanding of industry best practices in applying novel approaches to the development, manufacturing, and distribution of cell and gene therapies.

PDA today announced the confirmation of three U.S. FDA representatives as speakers at the 2023 PDA Advanced Therapy Medicinal Products Conference in Baltimore, Md., June 7-8. The three confirmed FDA speakers are all from Center for Biologics Evaluation and Research (CBER) and include:

· Tiffany Lucas, PhD, Gene Therapy CMC Reviewer

· Brenton K. McCright, PhD, Biologist

· Mikhail V. Ovanesov, PhD, Branch Chief

The conference’s theme, “Navigating through CMC Challenges,” was developed to ensure attendees expand their knowledge and understanding of industry best practices in applying novel approaches to the development, manufacturing, and distribution of cell and gene therapies.

Day 1 will kick off with a discussion on the intersection of clinical and regulatory strategy with CMC in order to advance innovative cell therapies toward approval. The plenary sessions that follow will give you an in-depth look at managing complex manufacturing networks, cell banking and ATMP development, and supply chain. Day 1 will close with the can’t miss networking reception where you can connect with peers and suppliers to build your network!

The agenda for Day 2 is also packed! Start this day with a breakfast session on exceptional release, followed by a plenary session on industry and agency perspectives for analytical method lifecycle steps, where you will explore valuable lessons learned from working in an accelerated development environment. Also on the agenda for Day 2 are plenary sessions covering raw material management and control, and a risk-based and science-driven approach to manufacturing process design and implementation.

Finally, you won’t want to miss the closing panel discussion with regulatory and industry panelists answering all your final questions that may not have been answered during the plenaries.

For more information or to register, go to: 2023 PDA Advanced Therapy Medicinal Products Conference.

Share article on social media or email:

Well-Respected NYC Facial Plastic Surgeon Dr. Lesley Rabach and Dermatologist Dr. Morgan Rabach have been Selected for Inclusion on the Super Doctors ® 2023 List for NYC


“It is an honor for us both to be on this year’s Super Doctors list. We strive to offer the best in facial plastic surgery and dermatology and provide a customized approach to meet each patient’s needs,” says Dr. Morgan Rabach.

Both Dr. Lesley Rabach and Dr. Morgan Rabach of LM Medical NYC have been chosen by Super Doctors® as two of the top doctors in New York for 2023. The number of physicians in each region receiving this honor is limited to approximately five percent. This award is given to the area’s best doctors in various medical specialties. The list of distinguished physicians will be published in an upcoming edition of The New York Times and online at http://www.superdoctors.com. Both doctors join an elite group of physicians earning this recognition. Super Doctors uses a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Dr. Lesley Rabach is double board certified in two facial plastic surgery fields, with a stellar reputation for creating natural, beautiful results for patients. Her extensive education, training and experience have earned accolades in her field, and she has been published in various medical journals. Dr. Morgan Rabach is a board-certified dermatologist who also has been recognized for her many accomplishments in dermatology and aesthetics. She has received many top rankings and has a substantial media presence in well-known beauty publications around the world.

“It is an honor for us both to be on this year’s Super Doctors list. We strive to offer the best in facial plastic surgery and dermatology and provide a customized approach to meet each patient’s needs,” says Dr. Morgan Rabach.

More about LM Medical NYC:

LM Medical NYC (Facial Plastic Surgery and Dermatology Specialists) is located at 33 Fifth Avenue #1B in New York, NY. As sisters and founders of the practice, Dr. Lesley Rabach, a board-certified facial plastic surgeon, and Dr. Morgan Rabach, a board-certified dermatologist, come together to provide the highest-quality medical, surgical and cosmetic care for patients at one location. This premier NYC practice offers expertise in two fields of medicine to help patients achieve the appearance they desire in a comfortable, upscale atmosphere. The clinic provides many services, ranging from the latest in clinical dermatology treatments to non-invasive cosmetic injections and youthful makeovers with plastic surgery. For more information or to schedule a consultation or appointment, please call 212-777-2272, or visit http://www.lmmedicalnyc.com.

Share article on social media or email:

The Evolution and Promise of Liquid Biopsy Technology, Upcoming Webinar Hosted by Xtalks


In this webinar, the featured speakers will explore the technique’s growing importance in early cancer detection and address common questions about its use.

As liquid biopsies become more commonplace, gaining wider US Food and Drug Administration (FDA) acceptance and even becoming standard of care in some instances, the technology is giving rise to important new questions. In this webinar, the featured speakers will explore the technique’s growing importance in early cancer detection and address common questions about its use.

The webinar will provide insights into developing an in vitro diagnostics test for early cancer detection with clinical, analytical and performance validation considerations. Attendees will learn how to approach single indication vs. multi-cancer screen indications, the advantages and disadvantages of lab-developed tests vs. premarket approval and the regulatory landscape for in vitro diagnostics. In addition, discover strategies for operationalizing large-scale clinical validation studies.

Attend this webinar on in vitro diagnostics for early cancer detection for a discussion on the evolution and promise of liquid biopsy technology.

Join experts from Premier Research, Matthew Nowland, Vice President, Regulatory Affairs; and Charlie Chrisawn, Executive Director, Program Strategy, In Vitro Diagnostics, for the live webinar on Thursday, May 25, 2023, at 11am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

RosettaHealth Finalist in NABOE Small Business Awards Program


News Image

“We are honored to be named a NABOE Small Business Award finalist,” said Buff Colchagoff, CEO of RosettaHealth. “Our solutions are designed to connect the whole world of healthcare.”

RosettaHealth, an innovative and secure, big health data interoperability platform, today announced that it has been named a finalist in the National Association of Business Owners & Entrepreneurs’ (NABOE) first annual small business award.

As a pioneer in creating solutions that enhance health data exchange, RosettaHealth was named a finalist for being on the forefront of breaking down the barriers of health data interoperability. This allows care organizations to enhance overall care quality, while also reducing the overall cost of care.

“We are honored to be named a NABOE Small Business Award finalist,” said Buff Colchagoff, CEO of RosettaHealth. “Our solutions are designed to connect the whole world of healthcare. We will continue to expand our digital health portfolio in ways that make health data truly ubiquitous and easy to access for better care outcomes.”

The founders of RosettaHealth originally worked with the Office of the National Coordinator (ONC) to define and deploy standards, create reference implementations, and establish the fabric of interoperability that is expanding across the industry today.

The award winners will be announced at NABOE’s Small Business Awards breakfast on May 18, 2023 at Lakewood Country Club in Rockville, MD.

The National Association of Business Owners & Entrepreneurs (NABOE) is a non-profit organization that provides resources and support to small businesses in the Washington, DC region. NABOE’s mission is to help small business owners grow and succeed by providing education, networking opportunities, and business performance enhancement.

About RosettaHealth

The RosettaHealth platform is making electronic health record exchange affordable and ubiquitous. Currently, more than 40 million health records move across the platform per month. The SaaS platform enables efficiencies, scale and ease not seen before in records exchange. For more information about RosettaHealth, please click here.

Share article on social media or email:

arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent


arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent

arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent

“We started arbOUR Products because we wanted high-quality products that were better for people, pets, and our planet,” said Carol Mehas, co-founder of arbOUR Products. “We are so proud to join the family of products that are CERTIFIED asthma & allergy friendly®”

May 10 2023: The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) have announced that arbOUR Products Free+Clear laundry detergent has been CERTIFIED by the asthma & allergy friendly®Certification Program. The asthma & allergy friendly® Certification Program helps consumers identify products for the home that are more suitable for people with asthma and allergies. Products undergo independent testing to meet scientific standards established by the program. The certification mark is only awarded to those products that pass those standards.To earn the certification, Free+Clear laundry detergent passed rigorous scientific testing and demonstrated:

  • Its ability to reduce over 95% of allergens related to pet dander and dust mites from fabrics washed with the detergent.
  • It has extremely low volatile organic compound (VOC) emissions when used.
  • Each ingredient has been reviewed to ensure that any chemicals with allergenic or sensitizing properties are either absent or at suitably low levels.

“We are delighted that arbOUR Products Free+Clear laundry detergent has joined the growing number of leading product manufacturers to achieve asthma & allergy friendly® Certification,” shared Dr. John McKeon, CEO of ASL. “Consumers can be confident that CERTIFIED laundry detergent can remove allergens like dust mite allergen and pet allergen, and that product claims are based on good science.”

“For people with asthma and allergies, reducing allergens is an important part of their asthma and allergy management plan,” said Kenneth Mendez, CEO and president of AAFA. “We congratulate arbOUR Products on earning the rigorous asthma & allergy friendly® Certification for its Free+Clear laundry detergent.”

arbOUR Products has demonstrated its commitment to providing high-quality and sustainable cleaning products that contribute to a healthier home environment with its newly CERTIFIED asthma & allergy friendly® Free+Clear laundry detergent.

“We started arbOUR Products because we wanted high-quality products that were better for people, pets, and our planet,” said Carol Mehas, co-founder of arbOUR Products. “We are so proud to join the family of products that are CERTIFIED asthma & allergy friendly® and for our Free+Clear detergent to be recognized to be of a higher standard for household and professional cleaning.”

About the asthma & allergy friendly® Certification Program

The asthma & allergy friendly® Certification Program is a unique, groundbreaking collaboration between the Asthma and Allergy Foundation of America and Allergy Standards Limited. This program helps people make informed purchases for a healthier home. The program tests products against strict standards. Products passing these tests earn the CERTIFIED asthma & allergy friendly® mark. Certified products include air cleaners, bedding, cleaning products, flooring, paints, vacuum cleaners, washing machines, and more. Visit aafa.org/certified for more information.

About arbOUR Products

arbOUR Products started as a labor of love by a mom, former product and brand developer, and lifelong seeker of a “better way” to clean. Unable to find what she was looking for on grocery and superstore shelves, she resolved to develop her own solution of commercial-strength cleaning products that actually work and are also sustainable, natural, and safe for the people, pets, and planet. Launched in summer 2022 with a range of home cleaning essentials, arbOUR is creating new solutions to age-old cleaning problems — from smarter stain-removers, to non-toxic ways to tackle stubborn odors, to hand wash made from sustainably sourced soapbark. arbOUR products are available exclusively on the arbourproducts.com website, where the arbOUR TREEHOUSE is building a community to redefine cleaning as less choreful, and more cheerful. For more good clean fun, visit arbourproducts.com.

Share article on social media or email:

Thrive Alliance Group to Present at NJASA/NJAPSA Spring Leadership Conference on Creating Academic Success Through Mental Health


News Image

“Student mental health initiatives should not merely be consigned to outside professionals, but should be embedded in school climate and culture so that students feel included and engaged,” said Amy Gallagher, Director of Special Services at Roxbury Public Schools.

Thrive Alliance Group, a nationally-recognized expert in fostering K–12 mental wellness, announces its presentation at the NJASA/NJAPSA Spring Leadership Conference happening May 17–19, 2023, at Caesars in Atlantic City. The presentation, Creating Academic Achievement Through Mental Health, will provide actionable strategies for school administrators to create a culture that supports students’ mental health and contributes to academic excellence. During the session, attendees will also learn from a New Jersey school district about how they have successfully implemented mental health services with practical takeaways to bring back to their school communities.

Mental health issues continue to impact students nationwide. A Centers for Disease Control and Prevention survey revealed that 44% of high school students report experiencing persistent sadness or hopelessness. In New Jersey, America’s School Mental Health Report Card found that 12.7% of children experienced a major depressive disorder in the past year; 58% did not receive treatment.

“The mental health of students is a growing concern that must be addressed in schools,” said Patricia Hovey, Executive Director at Thrive Alliance Group. “With 44% of high school students experiencing persistent sadness or hopelessness, it is essential that we provide educators with effective tools to address the underlying causes of dysregulation, such as trauma, anxiety or depression. Creating a culture of support and care for students is critical for academic success, and our presentation will help administrators achieve that.”

The ratio of students to school counselors in the United States continues to narrow. Recent data shows it has reached the lowest point since the American School Counselor Association (ASCA) began tracking student-to-counselor ratios in 1986. In New Jersey, there is one school counselor for every 320 students. The recommended ratio is one school counselor for every 250 students.

“Student mental health initiatives should not merely be consigned to outside professionals, but should be embedded in school climate and culture so that students feel included and engaged,” said Amy Gallagher, Director of Special Services at Roxbury Public Schools. “A sustained commitment to school climate and culture paves the way for happier, more committed and more effective teachers, administrators and staff. As a bonus, district costs decrease when struggling students no longer need the help of expensive out-of-district programs.”

Thrive Alliance Group is committed to providing educators with the tools to promote student well-being. By offering professional development, workshops, coaching and certification, placement of on-site therapists and mental wellness accreditation, Thrive is helping schools create a positive school climate and culture.

Visit Thrive Alliance Group at booth #21 to learn more about its on-site services and stop by their presentation, Creating Academic Achievement Through Mental Health, on Thursday, May 18, at 11:00 a.m. EDT. Thrive will also attend the NJEA Convention on November 9–10, 2023.

To learn more about Thrive Alliance Group, visit https://www.thrivealliancegroup.com/.

About Thrive Alliance Group

A nationally-recognized expert in fostering K–12 mental wellness, Thrive Alliance Group helps educators create a positive school climate and culture by offering professional development, workshops, coaching and certification, placement of on-site therapists and mental wellness accreditation. At Thrive Alliance Group, our team has deep clinical expertise in mental health as well as decades of experience serving students, families, schools and districts. We believe training leads to empowerment that has a lasting impact and transforms the lives of students. Our team includes special services administrators, mental health clinicians and coaches, curriculum development professionals, licenses clinical social workers, teachers and more. To learn more about Thrive Alliance Group, please visit https://www.thrivealliancegroup.com/.

Share article on social media or email:

How Humanized Mouse Models Enforce Preclinical Studies in Immuno-Oncology, Upcoming Webinar Hosted by Xtalks


Register for this webinar to discover the advantages of humanized mouse models for immunology and oncology preclinical studies, including the study of a novel long non-coding RNA (lncRNA) LISR-based therapeutic strategy.

In this webinar, attendees will learn more about the advantages of humanized mouse models for preclinical studies in immunology and oncology, how they can be used to study cancer therapies in vivo and a novel RNA-based cancer-specific therapeutic strategy to overcome intrinsic resistance to immune checkpoint blockade.

In the first part of this webinar, explore several case studies that demonstrate the advantages of using humanized mouse models to decipher different mechanisms of action such as immune checkpoint inhibitors, ADCC, T cell engagers and cell therapies.

In the second part of the webinar, explore the use of humanized mouse models transplanted with melanoma PDX to study a novel long non-coding RNA (lncRNA) LISR-based therapeutic strategy.

The featured study identifies an RNA-based cancer-specific therapeutic strategy to overcome intrinsic resistance to the immune checkpoint blockade.

Register for this webinar to discover the advantages of humanized mouse models for immunology and oncology preclinical studies, including the study of a novel long non-coding RNA (lncRNA) LISR-based therapeutic strategy.

Join Dan Georgess, PhD, Director of Alliance Management at TransCure bioServices; and Eleonora Leucci, PhD, Professor, Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, for the live webinar on Tuesday, May 30, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit How Humanized Mouse Models Enforce Preclinical Studies in Immuno-Oncology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent


arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent

arbOUR Products Earns asthma & allergy friendly® Certification for its Free+Clear Laundry Detergent

“We started arbOUR Products because we wanted high-quality products that were better for people, pets, and our planet,” said Carol Mehas, co-founder of arbOUR Products. “We are so proud to join the family of products that are CERTIFIED asthma & allergy friendly®”

The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) have announced that arbOUR Products Free+Clear laundry detergent has been CERTIFIED by the asthma & allergy friendly®Certification Program. The asthma & allergy friendly® Certification Program helps consumers identify products for the home that are more suitable for people with asthma and allergies. Products undergo independent testing to meet scientific standards established by the program. The certification mark is only awarded to those products that pass those standards.To earn the certification, Free+Clear laundry detergent passed rigorous scientific testing and demonstrated: Its ability to reduce over 95% of allergens related to pet dander and dust mites from fabrics washed with the detergent.

  • It has extremely low volatile organic compound (VOC) emissions when used.
  • Each ingredient has been reviewed to ensure that any chemicals with allergenic or sensitizing properties are either absent or at suitably low levels.

“We are delighted that arbOUR Products Free+Clear laundry detergent has joined the growing number of leading product manufacturers to achieve asthma & allergy friendly® Certification,” shared Dr. John McKeon, CEO of ASL. “Consumers can be confident that CERTIFIED laundry detergent can remove allergens like dust mite allergen and pet allergen, and that product claims are based on good science.”

“For people with asthma and allergies, reducing allergens is an important part of their asthma and allergy management plan,” said Kenneth Mendez, CEO and president of AAFA. “We congratulate arbOUR Products on earning the rigorous asthma & allergy friendly® Certification for its Free+Clear laundry detergent.”

arbOUR Products has demonstrated its commitment to providing high-quality and sustainable cleaning products that contribute to a healthier home environment with its newly CERTIFIED asthma & allergy friendly® Free+Clear laundry detergent.

“We started arbOUR Products because we wanted high-quality products that were better for people, pets, and our planet,” said Carol Mehas, co-founder of arbOUR Products. “We are so proud to join the family of products that are CERTIFIED asthma & allergy friendly® and for our Free+Clear detergent to be recognized to be of a higher standard for household and professional cleaning.”About the asthma & allergy friendly® Certification Program

The asthma & allergy friendly® Certification Program is a unique, groundbreaking collaboration between the Asthma and Allergy Foundation of America and Allergy Standards Limited. This program helps people make informed purchases for a healthier home. The program tests products against strict standards. Products passing these tests earn the CERTIFIED asthma & allergy friendly® mark. Certified products include air cleaners, bedding, cleaning products, flooring, paints, vacuum cleaners, washing machines, and more. Visit aafa.org/certified for more information.

About arbOUR Products

arbOUR Products started as a labor of love by a mom, former product and brand developer, and lifelong seeker of a “better way” to clean. Unable to find what she was looking for on grocery and superstore shelves, she resolved to develop her own solution of commercial-strength cleaning products that actually work and are also sustainable, natural, and safe for the people, pets, and planet. Launched in summer 2022 with a range of home cleaning essentials, arbOUR is creating new solutions to age-old cleaning problems — from smarter stain-removers, to non-toxic ways to tackle stubborn odors, to hand wash made from sustainably sourced soapbark. arbOUR products are available exclusively on the arbourproducts.com website, where the arbOUR TREEHOUSE is building a community to redefine cleaning as less choreful, and more cheerful. For more good clean fun, visit arbourproducts.com.

Share article on social media or email: